Tulmimetostat (DZR123)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tulmimetostat (DZR123), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome [Phase 1]